Literature DB >> 21095138

Implications for families of advances in understanding the genetic basis of epilepsy.

Carrie L Hammond1, Rhys H Thomas, Mark I Rees, Mike P Kerr, Frances Rapport.   

Abstract

Investigations into families with a large number of individuals with epilepsy have led to the discovery of epilepsy-causing (or epilepsy associated) gene mutations. These discoveries offer advantages and insights for the patient, family, healthcare professionals and biomedical scientists. Despite these benefits, there is little evidence about the impact of participation in genetic research for families with epilepsy. Here we report on the reflections of individuals who have participated in epilepsy genetic research through the Wales Epilepsy Research Network (WERN). Undergoing genetic investigation for inherited epilepsy has extensive emotive impact, both positive and negative, on individuals and families. Recognising these impacts is imperative to researchers working with families; having implications for study design, research consent and the provision of appropriate support.
Copyright © 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21095138     DOI: 10.1016/j.seizure.2010.10.022

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  3 in total

Review 1.  Genetic testing in the epilepsies-developments and dilemmas.

Authors:  Annapurna Poduri; Beth Rosen Sheidley; Sara Shostak; Ruth Ottman
Journal:  Nat Rev Neurol       Date:  2014-04-15       Impact factor: 42.937

Review 2.  The hidden genetics of epilepsy-a clinically important new paradigm.

Authors:  Rhys H Thomas; Samuel F Berkovic
Journal:  Nat Rev Neurol       Date:  2014-04-15       Impact factor: 42.937

3.  Barriers and facilitators to change in the organisation and delivery of endoscopy services in England and Wales: a focus group study.

Authors:  Frances Rapport; Anne C Seagrove; Hayley A Hutchings; Ian T Russell; Ivy Cheung; John G Williams; David Cohen
Journal:  BMJ Open       Date:  2012-06-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.